About this episode

Greg Meyers discusses the role of digital technology in transforming cancer diagnoses and treatment at Bristol Myers Squibb.

On the 69th episode of Enterprise AI Innovators, hosts Evan Reiser (CEO and co-founder, Abnormal AI) and Saam Motamedi (General Partner, Greylock Partners) are joined by Greg Meyers, Chief Digital and Technology Officer at Bristol Myers Squibb. Bristol Myers Squibb is one of the top ten pharmaceutical companies, with about 30,000 employees and roughly 45 billion dollars in annual revenue, making specialty medicines in oncology, immunology, and neurology. Greg shares how BMS puts commercially ...

Explore listener stats, chart rankings, contacts and more on the Enterprise AI Innovators podcast page.